Assessing Generalisability in Model-Based Economic Evaluation Studies: A Structured Review in Osteoporosis

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.24, Iss.12, 2006-01, pp. : 1181-1197

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A Critical Review of Model-Based Economic Studies of Depression: Modelling Techniques, Model Structure and Data Sources

By > Karnon Jonathan Gray Jodi

PharmacoEconomics, Vol. 30, Iss. 6, 2012-06 ,pp. : 461-482

Adis International

Access to resources Recommend Favorite

Model‐Based Evaluation of Radiation and Radiosensitizing Agents in Oncology

Cpt: Pharmacometrics & Systems Pharmacology, Vol. 7, Iss. 1, 2018-01 ,pp. : 51-58

John Wiley & Sons Inc

Access to resources Recommend Favorite

Cost Effectiveness of Raloxifene in the Treatment of Osteoporosis in Sweden: An Economic Evaluation Based on the MORE Study

By Fredrik Borgström Olof Johnell

PharmacoEconomics, Vol. 22, Iss. 17, 2004-01 ,pp. : 1153-1165

Adis International

Access to resources Recommend Favorite

The Cost Effectiveness of Bisphosphonates for the Prevention and Treatment of Osteoporosis: A Structured Review of the Literature

By Fleurence Rachael L.

PharmacoEconomics, Vol. 25, Iss. 11, 2007-01 ,pp. : 913-933

Adis International

Access to resources Recommend Favorite

The Generalisability of Pharmacoeconomic Studies: Issues and Challenges Ahead

By Mason James M.

PharmacoEconomics, Vol. 24, Iss. 10, 2006-01 ,pp. : 937-945

Adis International

Access to resources Recommend Favorite